Part 6/8:
Toward Targeted, Safer Treatments
Current treatments for inflammatory gut diseases often involve antibiotics and anti-inflammatory drugs like steroids. While effective, these treatments can have considerable side effects, damaging healthy tissues and causing other health issues. Milk nanoparticles, by contrast, offer a targeted approach: they naturally home in on the inflamed or damaged areas, delivering therapeutic effects precisely where needed.
This targeted delivery means higher efficacy with fewer side effects, reducing the collateral damage associated with conventional medications. Such precision medicine could revolutionize how we treat conditions like inflammatory bowel disease (IBD), Crohn’s disease, or ulcerative colitis.